Delivery Order SPE2DB22D3004-SPE2DB24FPW32
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $17,156.46 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $3,291.24 contract is for the supply of WEGOVY 2.4 mg/0.75 mL pens to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB22D2007|SPE2DB24FJ1MD) worth $1,257.04 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency awarded a $1,632.97 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The delivery order, valued at $1,097.08, has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. The contract has a ceiling value of $3,291.24 and a performance period through March 14, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $2,194.16 and a period of performance through April 9, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA with a potential value of...
- The Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $22,044.67, has a firm fixed price and an ultimate completion date of September 17, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this contract, which is not designated as a set-aside. This delivery order contract is part of a larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company, to provide the specialty medication WEGOVY 1 MG/0.5 ML PEN 0.5ML. The $1,773.81 delivery order has an ultimate completion date of March 26, 2024 and is not associated with any set-aside designation. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The contract is valued at $7,085.94 and has a period of performance through March 22, 2024. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPW32Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $3,291.24 contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this particular delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 4/4/24 |